Search

Author/Creator Peris, K

1. Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy. (2nd September 2021)

Authors:
Galluzzo, M; Caldarola, G; De Simone, C; Bernardini, N; Moretta, G; Pallotta, S; Botti, E; Campione, E; Pirro, F; Potenza, C.; Bianchi, L; Peris, K
Journal:
Expert opinion on biological therapy
Issue:
Volume 21:Number 9(2021)
Page Start:
1299
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AB0743 Low rates of major adverse cardiac events, malignancies, and serious infections in patients with psoriasis and psoriatic arthritis treated with apremilast for ≥156 weeks: pooled analysis from the esteem and palace 1-3 phase 3 trials. (15th June 2017)

Authors:
Kavanaugh, A; Augustin, M; Lespessailles, E; Papp, KA; Paris, M; Chen, R; Gladman, DD; Pariser, DM; Peris, K
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
1314
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study. (3rd April 2023)

Authors:
Caldarola, Giacomo; Chiricozzi, A; Megna, M; Dapavo, P; Giunta, A; Burlando, M; Malagoli, P; Dini, V; Mariani, M; Fabbrocini, G; Quaglino, P; Bianchi, L; Parodi, A; Peris, K; De Simone, C
Journal:
Expert opinion on biological therapy
Issue:
Volume 23:Number 4(2023)
Page Start:
365
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗